Non-viral expression of chimeric antigen receptors with multiplex gene editing in primary T cells

Efficient engineering of T cells to express exogenous tumor-targeting receptors such as chimeric antigen receptors (CARs) or T-cell receptors (TCRs) is a key requirement of effective adoptive cell therapy for cancer. Genome editing technologies, such as CRISPR/Cas9, can further alter the functional...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Dan Cappabianca, Jingling Li, Yueting Zheng, Cac Tran, Kassandra Kasparek, Pedro Mendez, Ricky Thu, Travis Maures, Christian M. Capitini, Robert Deans, Krishanu Saha
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-05-01
coleção:	Frontiers in Bioengineering and Biotechnology
Assuntos:	multiplex gene editing CRISPR/Cas9 GD2 chimeric antigen receptor T cells PD-1 neuroblastoma
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fbioe.2024.1379900/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!